- Joined
- Sep 25, 2010
- Messages
- 3,043
- Reaction score
- 14
I'm a bit curious so please forgive my ignorance. Is there a specific reason why NMDA antagonists, like ketamine , are usually trialled intravenously for depression? There is at least anecdotal evidence that dextromethphan, another NMDA antagonist, has similar effects when taken orally. Is it prohibitively expensive to produce a ketamine pill or is it just a money grab by the medical industrial complex? The cynical bastard in me would love to see Robitussin clinical trial for trd.